|
Real-time Estimate
Cboe BZX
15:14:08 21/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 556.87 USD | +0.54% |
|
+3.33% | +14.53% |
| Market Cap | 23.76B 21.15B 19.6B 17.76B 33.37B 2,251B 33.93B 235B 92.38B 1,178B 89.11B 87.26B 3,757B | P/E 2026 * |
20.8x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 21.05B 18.74B 17.36B 15.73B 29.57B 1,994B 30.07B 208B 81.85B 1,043B 78.95B 77.31B 3,329B | EV / Sales 2026 * |
6.59x | EV / Sales 2027 * | 5.48x |
| Free-Float |
53.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| UTHR | Delayed | |
CBOE
| UTHR | Real-time | |
Tradegate
| UTH | Real-time | |
Deutsche Boerse AG
| UTH | Delayed | |
Börse Stuttgart
| UTH | Delayed | |
Boerse Muenchen
| UTH | Real-time | |
Berne S.E.
| UTH | End-of-day quote | |
Xetra
| UTH | Delayed |
Last Transcript: United Therapeutics Corporation
| 1 day | +0.64% | ||
| 1 week | +3.33% | ||
| Current month | +2.98% | ||
| 1 month | +13.17% | ||
| 3 months | +4.14% | ||
| 6 months | -2.69% | ||
| Current year | +14.53% |
| 1 week | 530.18 | 564.97 | |
| 1 month | 468.97 | 585.79 | |
| Current year | 455.63 | 609.35 | |
| 1 year | 409.07 | 609.35 | |
| 3 years | 208.62 | 609.35 | |
| 5 years | 158.38 | 609.35 | |
| 10 years | 74.31 | 609.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 25/06/1996 | |
| President | 54 | 25/06/2016 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 12/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 31/12/2001 |
| Chairman | 71 | 25/06/1996 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 31/12/2001 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/10/26 | Exercice | Chief Executive Officer | 28,500 | 0.0664% | ||
| 15/10/26 | Exercice | General Counsel | 24,900 | 0.0581% | ||
| 14/10/26 | Exercice | Chief Executive Officer | 28,500 | 0.0664% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.54% | +3.33% | +32.09% | +148.99% | 23.76B | ||
| -1.11% | +5.39% | +59.32% | +120.91% | 1,144B | ||
| -1.50% | +0.76% | +33.33% | +68.99% | 625B | ||
| -1.06% | +0.92% | +23.64% | +97.67% | 511B | ||
| +0.32% | +5.53% | +39.39% | +64.77% | 377B | ||
| +0.29% | +1.06% | +69.97% | +44.10% | 366B | ||
| +0.22% | +3.34% | +21.23% | +50.01% | 291B | ||
| -0.01% | +2.86% | +1.43% | +25.27% | 262B | ||
| -0.43% | +2.71% | +45.34% | +60.29% | 237B | ||
| -2.33% | +0.38% | +24.21% | +98.71% | 194B | ||
| Average | -0.59% | +5.87% | +34.99% | +77.97% | 403.17B | |
| Weighted average by Cap. | -0.85% | +6.88% | +40.69% | +81.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2B 2.84B 2.64B 2.39B 4.49B 303B 4.57B 31.63B 12.43B 158B 11.99B 11.74B 505B | 3.64B 3.24B 3B 2.72B 5.11B 345B 5.2B 36.03B 14.15B 180B 13.65B 13.37B 576B |
| Net income | 1.22B 1.08B 1B 909M 1.71B 115B 1.74B 12.03B 4.73B 60.27B 4.56B 4.47B 192B | 1.45B 1.29B 1.19B 1.08B 2.03B 137B 2.07B 14.32B 5.62B 71.7B 5.43B 5.31B 229B |
| Net Debt | -2.71B -2.41B -2.23B -2.02B -3.8B -257B -3.87B -26.8B -10.53B -134B -10.16B -9.95B -428B | -3.81B -3.4B -3.15B -2.85B -5.36B -361B -5.45B -37.76B -14.83B -189B -14.31B -14.01B -603B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/10/26 | US$558.11 | +0.76% | 15,351 |
| 20/10/26 | US$553.88 | +1.98% | 443,279 |
| 19/10/26 | US$543.15 | +1.88% | 498,297 |
| 16/10/26 | US$533.12 | -1.55% | 668,250 |
| 15/10/26 | US$541.51 | +0.27% | 545,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions

















